Thomas Schlumpberger, a Doctor of Philosophy in Biology from the University of California, Berkeley, has an extensive background in the biotech industry. With his wealth of knowledge and experience, he has held various executive-level positions throughout his career, including Chief Executive Officer at Pictor, Director Board Of Directors at Dxeconomix, Executive Vice President Diagnostics at Anixa Biosciences, and Vice President Business Development at Inivata Limited, among many others.

His expertise in business development and strategic planning has been honed over the years through his work in companies such as Singulex, Annai Systems, Locus Development, Epocal Inc., Life Technologies, Nektar Therapeutics, Affymetrix, and Scimagix. Additionally, he was a Senior Associate at McKinsey & Company, where he gained valuable insights into management consulting.

Through his various roles, Thomas has had a significant impact on the development of molecular diagnostics, medical devices, and life science tools. He brings his expertise in commercialization, strategic planning, and business development to the table, making him an essential asset to any team.